{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:56:26Z","timestamp":1792173386769,"version":"4.4.0"},"reference-count":378,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T00:00:00Z","timestamp":1720742400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.phrs.2024.107308","type":"journal-article","created":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T19:37:53Z","timestamp":1721072273000},"page":"107308","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Brain gliomas: Diagnostic and therapeutic issues and the prospects of drug-targeted nano-delivery technology"],"prefix":"10.1016","volume":"206","author":[{"given":"Baoqin","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijing","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shehbaz","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1262-4182","authenticated-orcid":false,"given":"Wanjun","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2024.107308_bib1","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1093\/annonc\/mdz164","article-title":"Molecular pathology of tumors of the central nervous system","volume":"30","author":"Kristensen","year":"2019","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.phrs.2024.107308_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2020.02.002","article-title":"Immunotherapy for glioma: current management and future application","volume":"476","author":"Xu","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phrs.2024.107308_bib3","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s41582-022-00679-w","article-title":"Clinical implications of the 2021 edition of the WHO classification of central nervous system tumours","volume":"18","author":"Horbinski","year":"2022","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.phrs.2024.107308_bib4","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12943-022-01513-z","article-title":"Glioma targeted therapy: insight into future of molecular approaches","volume":"21","author":"Yang","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.phrs.2024.107308_bib5","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization classification of tumors of the central nervous system: a summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.phrs.2024.107308_bib6","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/s00259-023-06437-4","article-title":"Diagnostic accuracy of anti-3-[18F]-FACBC PET\/MRI in gliomas","volume":"51","author":"Karlberg","year":"2023","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.phrs.2024.107308_bib7","doi-asserted-by":"crossref","first-page":"v1","DOI":"10.1093\/neuonc\/noz150","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2012-2016","volume":"21","author":"Ostrom","year":"2019","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.phrs.2024.107308_bib8","article-title":"Long-term neurocognitive and other side effects of radiotherapy, with or without chemotherapy, for glioma","volume":"8","author":"Lawrie","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.phrs.2024.107308_bib9","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.jcis.2024.01.130","article-title":"Multifunctional Two-Dimensional Bi2Se3 nanodisks as a Non-Inflammatory photothermal agent for glioma treatment","volume":"661","author":"Dai","year":"2024","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.phrs.2024.107308_bib10","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.pharmthera.2015.05.005","article-title":"Glioblastoma multiforme: pathogenesis and treatment","volume":"152","author":"Alifieris","year":"2015","journal-title":"Pharm. Ther."},{"key":"10.1016\/j.phrs.2024.107308_bib11","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1146\/annurev-pathmechdis-051122-110348","article-title":"Role of the microenvironment in glioma pathogenesis","volume":"19","author":"Jayaram","year":"2024","journal-title":"Annu. Rev. Pathol.: Mech. Dis."},{"key":"10.1016\/j.phrs.2024.107308_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155274","article-title":"Artesunate in glioblastoma therapy: case reports and review of clinical studies","volume":"123","author":"Strik","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phrs.2024.107308_bib13","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14698","article-title":"Deep-targeted gene sequencing reveals ARID1A mutation as an important driver of glioblastoma","volume":"30","author":"Xiao","year":"2024","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.phrs.2024.107308_bib14","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth","volume":"41","author":"de Visser","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.phrs.2024.107308_bib15","article-title":"Personalized cancer nanomedicine: overcoming biological barriers for intracellular delivery of biopharmaceuticals","volume":"36","author":"L\u00f3pez-Est\u00e9vez","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.phrs.2024.107308_bib16","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s11060-024-04600-x","article-title":"Repeated surgical resections for management of high-grade glioma and its impact on quality of life","volume":"167","author":"Koay","year":"2024","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.phrs.2024.107308_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.3020","article-title":"Preoperative symptoms of depression, anxiety, and cognitive impairment in glioma patients: a cerebral perfusion CT study","volume":"13","author":"Wang","year":"2023","journal-title":"Brain Behav."},{"key":"10.1016\/j.phrs.2024.107308_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1221753","article-title":"White matter tracts contribute selectively to cognitive functioning in patients with glioma","volume":"13","author":"Andreoli","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.phrs.2024.107308_bib19","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1148\/radiol.210820","article-title":"Whole-tumor histogram analysis of multiple diffusion metrics for glioma genotyping","volume":"302","author":"Gao","year":"2022","journal-title":"Radiology"},{"key":"10.1016\/j.phrs.2024.107308_bib20","doi-asserted-by":"crossref","first-page":"488","DOI":"10.2967\/jnumed.118.222893","article-title":"Introduction to radiomics","volume":"61","author":"Mayerhoefer","year":"2020","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.phrs.2024.107308_bib21","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.canlet.2020.02.025","article-title":"Imaging of intratumoral heterogeneity in high-grade glioma","volume":"477","author":"Hu","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phrs.2024.107308_bib22","first-page":"645","article-title":"The implications of IDH mutations for cancer development and therapy, Nature reviews","volume":"18","author":"Pirozzi","year":"2021","journal-title":"Clin. Oncol."},{"key":"10.1016\/j.phrs.2024.107308_bib23","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.trecan.2020.02.010","article-title":"MGMT status as a clinical biomarker in glioblastoma","volume":"6","author":"Butler","year":"2020","journal-title":"Trends Cancer"},{"key":"10.1016\/j.phrs.2024.107308_bib24","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00401-021-02337-9","article-title":"TERT promoter mutation status is necessary and sufficient to diagnose IDH-wildtype diffuse astrocytic glioma with molecular features of glioblastoma","volume":"142","author":"Fujimoto","year":"2021","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.phrs.2024.107308_bib25","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1016\/j.molcel.2022.09.024","article-title":"Argininosuccinate lyase drives activation of mutant TERT promoter in glioblastomas","volume":"82","author":"Shi","year":"2022","journal-title":"Mol. Cell"},{"key":"10.1016\/j.phrs.2024.107308_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910373","article-title":"Prognostic and predictive biomarkers in gliomas","volume":"22","author":"\u015aledzi\u0144ska","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2024.107308_bib27","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1093\/neuonc\/noad100","article-title":"Molecular diagnostic tools for the World Health Organization (WHO) 2021 classifcation of gliomas, glioneuronal and neuronal tumors; an EANO guideline","volume":"25","author":"Sahm","year":"2023","journal-title":"Neuro-Oncol."},{"key":"10.1016\/j.phrs.2024.107308_bib28","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jconrel.2023.05.016","article-title":"Nanobiotechnology-based treatment strategies for malignant relapsed glioma","volume":"358","author":"Qiu","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.phrs.2024.107308_bib29","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.jconrel.2022.07.023","article-title":"Polymeric nanoparticles for drug delivery in glioblastoma: state of the art and future perspectives","volume":"349","author":"Madani","year":"2022","journal-title":"J. Control Release"},{"key":"10.1016\/j.phrs.2024.107308_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14215389","article-title":"Smart nanoformulations for brain cancer theranostics: challenges and promises","volume":"14","author":"Ahmad","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.phrs.2024.107308_bib31","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.carbpol.2013.07.021","article-title":"Polyamidoamine dendrimer conjugated chitosan nanoparticles for the delivery of methotrexate","volume":"98","author":"Leng","year":"2013","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.phrs.2024.107308_bib32","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3171\/2018.10.JNS181519","article-title":"Insular glioma surgery: an evolution of thought and practice","volume":"130","author":"Hervey-Jumper","year":"2019","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.phrs.2024.107308_bib33","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3897\/folmed.64.e62981","article-title":"\"Security dilemma\": active immunotherapy before versus after radiation therapy alone or chemo-radiotherapy for newly diagnosed glioblastoma","volume":"64","author":"Nikova","year":"2022","journal-title":"Folia Med."},{"key":"10.1016\/j.phrs.2024.107308_bib34","first-page":"330","article-title":"Chitosan-based nanosystems for cancer diagnosis and therapy: stimuli-responsive, immune response, and clinical studies","author":"Moghaddam","year":"2024","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.phrs.2024.107308_bib35","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1021\/acs.molpharmaceut.1c00856","article-title":"Research progress on nanoplatforms and nanotherapeutic strategies in treating glioma","volume":"19","author":"Qiao","year":"2022","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.phrs.2024.107308_bib36","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.2147\/IJN.S243223","article-title":"Nanoparticle drug delivery system for glioma and its efficacy improvement strategies: a comprehensive review","volume":"15","author":"Li","year":"2020","journal-title":"Int J. Nanomed."},{"key":"10.1016\/j.phrs.2024.107308_bib37","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41419-019-2200-2","article-title":"Identification of a transient state during the acquisition of temozolomide resistance in glioblastoma","volume":"11","author":"Rab\u00e9","year":"2020","journal-title":"Cell death Dis."},{"key":"10.1016\/j.phrs.2024.107308_bib38","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/j.celrep.2013.04.035","article-title":"Transcriptional differences between normal and glioma-derived glial progenitor cells identify a core set of dysregulated genes","volume":"3","author":"Auvergne","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.phrs.2024.107308_bib39","first-page":"133","article-title":"Macrophages and microglia in glioblastoma: heterogeneity, plasticity, and therapy","author":"Khan","year":"2023","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.phrs.2024.107308_bib40","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.biomaterials.2013.09.094","article-title":"Nanoparticles of 2-deoxy-D-glucose functionalized poly(ethylene glycol)-co-poly(trimethylene carbonate) for dual-targeted drug delivery in glioma treatment","volume":"35","author":"Jiang","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.phrs.2024.107308_bib41","doi-asserted-by":"crossref","first-page":"4308","DOI":"10.7150\/thno.41322","article-title":"Muscone\/RI7217 co-modified upward messenger DTX liposomes enhanced permeability of blood-brain barrier and targeting glioma","volume":"10","author":"Kang","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.phrs.2024.107308_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2021.117907","article-title":"pH-controlled nucleolin targeted release of dual drug from chitosan-gold based aptamer functionalized nano drug delivery system for improved glioblastoma treatment","volume":"262","author":"Sathiyaseelan","year":"2021","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.phrs.2024.107308_bib43","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jconrel.2022.07.008","article-title":"Indocarbocyanine nanoparticles extravasate and distribute better than liposomes in brain tumors","volume":"349","author":"Balyasnikova","year":"2022","journal-title":"J. Control Release"},{"key":"10.1016\/j.phrs.2024.107308_bib44","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1021\/acsnano.1c05505","article-title":"Immune checkpoint inhibition in GBM Primed with Radiation by Engineered Extracellular Vesicles","volume":"16","author":"Tian","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.phrs.2024.107308_bib45","article-title":"The blood\u2013brain barrier: structure, regulation, and drug delivery","volume":"8","author":"Wu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.phrs.2024.107308_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114820","article-title":"Engineered nanomaterials that exploit blood-brain barrier dysfunction for delivery to the brain","volume":"197","author":"Wu","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.phrs.2024.107308_bib47","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.jconrel.2024.03.019","article-title":"A quantitative MRI-based approach to estimate the permeation and retention of nanomedicines in tumors","volume":"368","author":"Nomani","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.phrs.2024.107308_bib48","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1021\/acsnano.3c10674","article-title":"Functionalized Nanomaterials Capable of Crossing the Blood\u2013Brain Barrier","volume":"18","author":"Zha","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.phrs.2024.107308_bib49","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","article-title":"The blood-brain barrier: structure, regulation, and drug delivery","volume":"8","author":"Wu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.phrs.2024.107308_bib50","doi-asserted-by":"crossref","first-page":"16840","DOI":"10.1021\/acsnano.3c03724","article-title":"Dual-Site F\u00f6rster resonance energy transfer route of upconversion nanoparticles-based brain-targeted nanotheranostic boosts the near-infrared phototherapy of glioma","volume":"17","author":"Wang","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.phrs.2024.107308_bib51","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jconrel.2023.11.033","article-title":"Targeted delivery of hybrid nanovesicles for enhanced brain penetration to achieve synergistic therapy of glioma","volume":"365","author":"Wang","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.phrs.2024.107308_bib52","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1056\/NEJMra0912273","article-title":"Nanomedicine","volume":"363","author":"Kim","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2024.107308_bib53","article-title":"Role of nanomedicine-based therapeutics in the treatment of CNS disorders","volume":"28","author":"Guo","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.phrs.2024.107308_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123069","article-title":"Cellular drug delivery system for disease treatment","volume":"641","author":"Wang","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.phrs.2024.107308_bib55","doi-asserted-by":"crossref","DOI":"10.1007\/s13346-024-01591-0","article-title":"Cell-mediated nanoparticle delivery systems: towards precision nanomedicine","author":"Cheng","year":"2024","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.phrs.2024.107308_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2023.120201","article-title":"Miniaturized MR-compatible ultrasound system for real-time monitoring of acoustic effects in mice using high-resolution MRI","volume":"276","author":"Kim","year":"2023","journal-title":"NeuroImage"},{"key":"10.1016\/j.phrs.2024.107308_bib57","first-page":"4104","article-title":"On the information theory for magnetic resonance imaging","volume":"2021","author":"Calderon-Rico","year":"2021","journal-title":"Annu. Int. Conf. IEEE Eng. Med. Biol. Soc. IEEE Eng. Med. Biol. Soc. Annu. Int. Conf."},{"key":"10.1016\/j.phrs.2024.107308_bib58","article-title":"Structure-relaxivity relationships of magnetic nanoparticles for magnetic resonance imaging","volume":"31","author":"Zhou","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.phrs.2024.107308_bib59","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1148\/radiol.2021203281","article-title":"Biologic pathways underlying prognostic radiomics phenotypes from paired MRI and RNA sequencing in glioblastoma","volume":"301","author":"Sun","year":"2021","journal-title":"Radiology"},{"key":"10.1016\/j.phrs.2024.107308_bib60","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/WCO.0000000000000950","article-title":"Update on neuroimaging in brain tumours","volume":"34","author":"Smits","year":"2021","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.phrs.2024.107308_bib61","first-page":"206","article-title":"Principles and current trends in the correlative evaluation of glioma with advanced MRI techniques and PET","volume":"22","author":"Tsiouris","year":"2019","journal-title":"Hell. J. Nucl. Med."},{"key":"10.1016\/j.phrs.2024.107308_bib62","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/RMR.0000000000000232","article-title":"Emerging techniques in imaging of glioma microenvironment","volume":"29","author":"Nabavizadeh","year":"2020","journal-title":"Top. Magn. Reson. Imaging.: TMRI"},{"key":"10.1016\/j.phrs.2024.107308_bib63","doi-asserted-by":"crossref","first-page":"236","DOI":"10.31486\/toj.17.0062","article-title":"Advances in neuro-oncology imaging techniques","volume":"18","author":"O'Neill","year":"2018","journal-title":"Ochsner J."},{"key":"10.1016\/j.phrs.2024.107308_bib64","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1097\/RLU.0000000000004341","article-title":"11C-Acetate PET\/CT detects reactive astrogliosis helping glioma classification","volume":"47","author":"Kim","year":"2022","journal-title":"Clin. Nucl. Med."},{"key":"10.1016\/j.phrs.2024.107308_bib65","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14051103","article-title":"PET imaging in neuro-oncology: an update and overview of a rapidly growing area","volume":"14","author":"Verger","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.phrs.2024.107308_bib66","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1093\/neuonc\/now058","article-title":"Response assessment in neuro-oncology working group and European Association for neuro-oncology recommendations for the clinical use of PET imaging in gliomas","volume":"18","author":"Albert","year":"2016","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.phrs.2024.107308_bib67","first-page":"26","article-title":"Nanosensitizers for sonodynamic therapy for glioblastoma multiforme: current progress and future perspectives","volume":"9","author":"Guo","year":"2022","journal-title":"Mil. Med. Res."},{"key":"10.1016\/j.phrs.2024.107308_bib68","article-title":"Nanobody-A versatile tool for cancer diagnosis and therapeutics","volume":"13","author":"Liu","year":"2021","journal-title":"Wiley Inter. Rev. Nanomed. Nanobiotechnol"},{"key":"10.1016\/j.phrs.2024.107308_bib69","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1021\/acsnano.8b00076","article-title":"Size-modulable nanoprobe for high-performance ultrasound imaging and drug delivery against cancer","volume":"12","author":"Zhang","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.phrs.2024.107308_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121287","article-title":"Inhibiting autophagy flux and DNA repair of tumor cells to boost radiotherapy of orthotopic glioblastoma","volume":"280","author":"Xu","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.phrs.2024.107308_bib71","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.2147\/IJN.S165210","article-title":"Application of active targeting nanoparticle delivery system for chemotherapeutic drugs and traditional\/herbal medicines in cancer therapy: a systematic review","volume":"13","author":"Muhamad","year":"2018","journal-title":"Int J. Nanomed."},{"key":"10.1016\/j.phrs.2024.107308_bib72","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1016\/j.biomaterials.2012.11.048","article-title":"Antiangiogenic-targeting drug-loaded microbubbles combined with focused ultrasound for glioma treatment","volume":"34","author":"Fan","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.phrs.2024.107308_bib73","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1200\/JCO.21.02036","article-title":"Therapy for diffuse astrocytic and oligodendroglial tumors in adults: ASCO-SNO guideline","volume":"40","author":"Mohile","year":"2022","journal-title":"J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.phrs.2024.107308_bib74","doi-asserted-by":"crossref","first-page":"e330","DOI":"10.1016\/S1470-2045(17)30345-5","article-title":"European Association for neuro-oncology (EANO) guidelines for palliative care in adults with glioma","volume":"18","author":"Pace","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.phrs.2024.107308_bib75","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/cncr.31113","article-title":"Literacy analysis of national comprehensive cancer network patient guidelines for the most common malignancies in the United States","volume":"124","author":"Tran","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.phrs.2024.107308_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113951","article-title":"Rationally designed drug delivery systems for the local treatment of resected glioblastoma","volume":"177","author":"Bastiancich","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.phrs.2024.107308_bib77","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nrclinonc.2017.171","article-title":"Surgical oncology for gliomas: the state of the art","volume":"15","author":"Sanai","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.phrs.2024.107308_bib78","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3171\/2011.2.JNS10998","article-title":"An extent of resection threshold for newly diagnosed glioblastomas","volume":"115","author":"Sanai","year":"2011","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.phrs.2024.107308_bib79","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1093\/neuonc\/nor133","article-title":"Correlation of the extent of tumor volume resection and patient survival in surgery of glioblastoma multiforme with high-field intraoperative MRI guidance","volume":"13","author":"Kuhnt","year":"2011","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.phrs.2024.107308_bib80","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1245\/s10434-017-5843-1","article-title":"Patient-specific resection strategy of glioblastoma multiforme: choice based on a preoperative scoring scale","volume":"24","author":"Jiang","year":"2017","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.phrs.2024.107308_bib81","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3171\/jns.2001.95.2.0190","article-title":"A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival","volume":"95","author":"Lacroix","year":"2001","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.phrs.2024.107308_bib82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10143-016-0709-8","article-title":"Current and future strategies for treatment of glioma","volume":"40","author":"Bush","year":"2017","journal-title":"Neurosurg. Rev."},{"key":"10.1016\/j.phrs.2024.107308_bib83","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.addr.2021.01.012","article-title":"Frontiers in the treatment of glioblastoma: past, present and emerging","volume":"171","author":"Janjua","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.phrs.2024.107308_bib84","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202109189","article-title":"Mucus penetrating and cell-binding polyzwitterionic micelles as potent oral nanomedicine for cancer drug delivery","volume":"34","author":"Fan","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.phrs.2024.107308_bib85","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2021.2224","article-title":"Efficacy of carboplatin and isotretinoin in children with high-risk medulloblastoma","volume":"7","author":"Leary","year":"2021","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.phrs.2024.107308_bib86","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202211980","article-title":"Hydrophobicity-adaptive polymers trigger fission of tumor-cell-derived microparticles for enhanced anticancer drug delivery","volume":"35","author":"Liu","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.phrs.2024.107308_bib87","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ejpb.2021.08.011","article-title":"Improving temozolomide biopharmaceutical properties in glioblastoma multiforme (GBM) treatment using GBM-targeting nanocarriers","volume":"168","author":"Delello Di Filippo","year":"2021","journal-title":"Eur. J. Pharm. Biopharm.: Off. J. Arb. fur Pharm. Verfahr. e. V."},{"key":"10.1016\/j.phrs.2024.107308_bib88","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1001\/jama.1972.03210050021004","article-title":"The chemotherapy of brain tumors. Clinical experience with carmustine (BCNU) and vincristine","volume":"222","author":"Fewer","year":"1972","journal-title":"Jama"},{"key":"10.1016\/j.phrs.2024.107308_bib89","doi-asserted-by":"crossref","first-page":"4736","DOI":"10.1111\/cas.15141","article-title":"Lomustine and nimustine exert efficient antitumor effects against glioblastoma models with acquired temozolomide resistance","volume":"112","author":"Yamamuro","year":"2021","journal-title":"Cancer Sci."},{"key":"10.1016\/j.phrs.2024.107308_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107922","article-title":"Genotoxic therapy and resistance mechanism in gliomas","volume":"228","author":"Lang","year":"2021","journal-title":"Pharm. Ther."},{"key":"10.1016\/j.phrs.2024.107308_bib91","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jconrel.2022.09.065","article-title":"Glioma diagnosis and therapy: current challenges and nanomaterial-based solutions","volume":"352","author":"Li","year":"2022","journal-title":"J. Control Release"},{"key":"10.1016\/j.phrs.2024.107308_bib92","doi-asserted-by":"crossref","first-page":"55851","DOI":"10.1021\/acsami.1c16962","article-title":"Visible light and glutathione dually responsive delivery of a polymer-conjugated temozolomide intermediate for glioblastoma chemotherapy","volume":"13","author":"Du","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.phrs.2024.107308_bib93","first-page":"309","article-title":"Absorption, metabolism, and excretion of 14C-temozolomide following oral administration to patients with advanced cancer, Clinical cancer research: an official","volume":"5","author":"Baker","year":"1999","journal-title":"J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.phrs.2024.107308_bib94","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.pharmthera.2017.10.017","article-title":"Glioblastoma and chemoresistance to alkylating agents: Involvement of apoptosis, autophagy, and unfolded protein response","volume":"184","author":"Hombach-Klonisch","year":"2018","journal-title":"Pharm. Ther."},{"key":"10.1016\/j.phrs.2024.107308_bib95","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/nrneurol.2014.100","article-title":"MGMT testing--the challenges for biomarker-based glioma treatment","volume":"10","author":"Wick","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.phrs.2024.107308_bib96","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1001\/jamaoncol.2018.1977","article-title":"Association of MGMT promoter methylation status with survival outcomes in patients with high-risk glioma treated with radiotherapy and temozolomide: an analysis from the NRG oncology\/RTOG 0424 Trial","volume":"4","author":"Bell","year":"2018","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.phrs.2024.107308_bib97","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2176\/nmc.ra.2018-0141","article-title":"Potential strategies overcoming the temozolomide resistance for glioblastoma","volume":"58","author":"Jiapaer","year":"2018","journal-title":"Neurol. Med. -Chir."},{"key":"10.1016\/j.phrs.2024.107308_bib98","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1158\/1078-0432.CCR-19-2000","article-title":"Restoration of temozolomide sensitivity by PARP inhibitors in mismatch repair deficient glioblastoma is independent of base excision repair","volume":"26","author":"Higuchi","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.phrs.2024.107308_bib99","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/1878-0261.12076","article-title":"Dovitinib enhances temozolomide efficacy in glioblastoma cells","volume":"11","author":"Thanasupawat","year":"2017","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.phrs.2024.107308_bib100","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/s41586-020-2209-9","article-title":"Mechanisms and therapeutic implications of hypermutation in gliomas","volume":"580","author":"Touat","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2024.107308_bib101","article-title":"\u03b2-elemene combined with temozolomide in treatment of brain glioma","volume":"28","author":"Zhang","year":"2021","journal-title":"Biochem. Biophys. Rep."},{"key":"10.1016\/j.phrs.2024.107308_bib102","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S0140-6736(18)31791-4","article-title":"Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG\/NOA-09): a randomised, open-label, phase 3 trial","volume":"393","author":"Herrlinger","year":"2019","journal-title":"Lancet (Lond., Engl. )"},{"key":"10.1016\/j.phrs.2024.107308_bib103","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1021\/acsami.2c03538","article-title":"Nanomedicines targeting glioma stem cells","volume":"15","author":"Sabu","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.phrs.2024.107308_bib104","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.apsb.2021.08.013","article-title":"Gather wisdom to overcome barriers: Well-designed nano-drug delivery systems for treating gliomas","volume":"12","author":"Cui","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.phrs.2024.107308_bib105","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.7150\/thno.38147","article-title":"Nanocarrier-based drug combination therapy for glioblastoma","volume":"10","author":"Zhao","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.phrs.2024.107308_bib106","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1080\/1061186X.2022.2119243","article-title":"Progress in research and development of temozolomide brain-targeted preparations: a review","volume":"31","author":"Yang","year":"2023","journal-title":"J. Drug Target."},{"key":"10.1016\/j.phrs.2024.107308_bib107","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/cncr.21324","article-title":"The role of radiotherapy in cancer treatment: estimating optimal utilization from a review of evidence-based clinical guidelines","volume":"104","author":"Delaney","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.phrs.2024.107308_bib108","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.addr.2017.01.004","article-title":"Radiotherapy for cancer: present and future","volume":"109","author":"Allen","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.phrs.2024.107308_bib109","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.radonc.2021.12.009","article-title":"Chemoradiotherapy with temozolomide vs. radiotherapy alone in patients with IDH wild-type and TERT promoter mutation WHO grade II\/III gliomas: a prospective randomized study","volume":"167","author":"Qiu","year":"2022","journal-title":"Radiother. Oncol.: J. Eur. Soc. Ther. Radiol. Oncol."},{"key":"10.1016\/j.phrs.2024.107308_bib110","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1158\/1078-0432.CCR-21-4283","article-title":"Temozolomide and radiotherapy versus radiotherapy alone in patients with glioblastoma, IDH-wildtype: post hoc analysis of the EORTC randomized phase III CATNON trial","volume":"28","author":"Tesileanu","year":"2022","journal-title":"Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.phrs.2024.107308_bib111","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1001\/jama.2022.13997","article-title":"Effect of Radiotherapy alone vs radiotherapy with concurrent chemoradiotherapy on survival without disease relapse in patients with low-risk nasopharyngeal carcinoma: a randomized clinical trial","volume":"328","author":"Tang","year":"2022","journal-title":"Jama"},{"key":"10.1016\/j.phrs.2024.107308_bib112","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.1158\/0008-5472.CAN-19-0680","article-title":"Radiation-induced DNA damage cooperates with heterozygosity of TP53 and PTEN to generate high-grade gliomas","volume":"79","author":"Todorova","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.phrs.2024.107308_bib113","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.gde.2020.12.002","article-title":"Spatially resolved transcriptomics and its applications in cancer","volume":"66","author":"Maniatis","year":"2021","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.phrs.2024.107308_bib114","doi-asserted-by":"crossref","first-page":"1255611","DOI":"10.3389\/fimmu.2023.1255611","article-title":"Immunotherapy: a promising approach for glioma treatment","volume":"14","author":"Yasinjan","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2024.107308_bib115","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13215452","article-title":"Oncolytic viruses: newest frontier for cancer immunotherapy","volume":"13","author":"Rahman","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.phrs.2024.107308_bib116","doi-asserted-by":"crossref","first-page":"4828","DOI":"10.1200\/JCO.2011.38.0899","article-title":"Cancer immunotherapy comes of age","volume":"29","author":"Topalian","year":"2011","journal-title":"J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.phrs.2024.107308_bib117","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1093\/neuonc\/noad108","article-title":"Chimeric antigen receptor T cell-based targeting of CD317 as a novel immunotherapeutic strategy against glioblastoma","volume":"25","author":"H\u00e4nsch","year":"2023","journal-title":"Neuro-Oncol."},{"key":"10.1016\/j.phrs.2024.107308_bib118","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/s43018-023-00591-2","article-title":"ALK peptide vaccination restores the immunogenicity of ALK-rearranged non-small cell lung cancer","volume":"4","author":"Mota","year":"2023","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.phrs.2024.107308_bib119","doi-asserted-by":"crossref","first-page":"6702","DOI":"10.1021\/acsnano.4c01050","article-title":"Biologically self-assembled tumor cell-derived cancer nanovaccines as an all-in-one platform for cancer immunotherapy","volume":"18","author":"Liang","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.phrs.2024.107308_bib120","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1038\/s41401-022-00910-w","article-title":"Engineered nanomedicines block the PD-1\/PD-L1 axis for potentiated cancer immunotherapy","volume":"43","author":"Li","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.phrs.2024.107308_bib121","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2022.100907","article-title":"Research progress of therapeutic effects and drug resistance of immunotherapy based on PD-1\/PD-L1 blockade","volume":"66","author":"Pang","year":"2023","journal-title":"Drug Resist. Update.: Rev. Comment. Antimicrob. Anticancer Chemother."},{"key":"10.1016\/j.phrs.2024.107308_bib122","first-page":"153","article-title":"The diverse functions of the PD1 inhibitory pathway, Nature reviews","volume":"18","author":"Sharpe","year":"2018","journal-title":"Immunology"},{"key":"10.1016\/j.phrs.2024.107308_bib123","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev-immunol-070621-030155","article-title":"Resistance mechanisms to anti-PD cancer immunotherapy","volume":"40","author":"Vesely","year":"2022","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.phrs.2024.107308_bib124","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12943-021-01489-2","article-title":"Combination strategies with PD-1\/PD-L1 blockade: current advances and future directions","volume":"21","author":"Yi","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.phrs.2024.107308_bib125","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13046-022-02251-2","article-title":"Immunotherapy for glioblastoma: the promise of combination strategies","volume":"41","author":"Bausart","year":"2022","journal-title":"J. Exp. Clin. Cancer Res.: CR"},{"key":"10.1016\/j.phrs.2024.107308_bib126","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.trecan.2022.10.003","article-title":"The emerging field of oncolytic virus-based cancer immunotherapy","volume":"9","author":"Ma","year":"2023","journal-title":"Trends Cancer"},{"key":"10.1016\/j.phrs.2024.107308_bib127","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/77558","article-title":"Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus","volume":"6","author":"Stojdl","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.phrs.2024.107308_bib128","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003578","article-title":"Cell carriage, delivery, and selective replication of an oncolytic virus in tumor in patients","volume":"4","author":"Adair","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.phrs.2024.107308_bib129","doi-asserted-by":"crossref","first-page":"683","DOI":"10.3389\/fimmu.2020.00683","article-title":"Combining oncolytic viruses with cancer immunotherapy: establishing a new generation of cancer treatment","volume":"11","author":"Shi","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2024.107308_bib130","doi-asserted-by":"crossref","first-page":"6812","DOI":"10.1073\/pnas.1701002114","article-title":"Selective replication of oncolytic virus M1 results in a bystander killing effect that is potentiated by Smac mimetics","volume":"114","author":"Cai","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phrs.2024.107308_bib131","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/gt.2014.113","article-title":"Enhancing the bystander killing effect of an oncolytic HSV by arming it with a secretable apoptosis activator","volume":"22","author":"Loya","year":"2015","journal-title":"Gene Ther."},{"key":"10.1016\/j.phrs.2024.107308_bib132","article-title":"Heating it up: Oncolytic viruses make tumors 'hot' and suitable for checkpoint blockade immunotherapies","volume":"7","author":"Gujar","year":"2018","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.phrs.2024.107308_bib133","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1200\/JCO.2017.75.8219","article-title":"Phase I study of DNX-2401 (Delta-24-RGD) oncolytic adenovirus: replication and immunotherapeutic effects in recurrent malignant glioma","volume":"36","author":"Lang","year":"2018","journal-title":"J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.phrs.2024.107308_bib134","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1056\/NEJMoa2202028","article-title":"Oncolytic DNX-2401 VIrus for Pediatric Diffuse Intrinsic Pontine Glioma","volume":"386","author":"G\u00e1llego P\u00e9rez-Larraya","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2024.107308_bib135","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1056\/NEJMoa1716435","article-title":"Recurrent glioblastoma treated with recombinant poliovirus","volume":"379","author":"Desjardins","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2024.107308_bib136","first-page":"1818","article-title":"Oncolytic viral therapy for malignant glioma and their application in clinical practice","volume":"19","author":"Shoaf","year":"2022","journal-title":"Neurother.\u00a0J. Am. Soc. Exp. Neurother."},{"key":"10.1016\/j.phrs.2024.107308_bib137","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.1158\/0008-5472.CAN-04-0083","article-title":"Disruption of cancer cell replication by alternating electric fields","volume":"64","author":"Kirson","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.phrs.2024.107308_bib138","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.ygyno.2018.07.018","article-title":"Tumor Treating Fields in combination with paclitaxel in recurrent ovarian carcinoma: results of the INNOVATE pilot study","volume":"150","author":"Vergote","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.phrs.2024.107308_bib139","doi-asserted-by":"crossref","DOI":"10.3390\/antiox8050112","article-title":"The flavonoid quercetin induces AP-1 activation in FRTL-5 thyroid cells","volume":"8","author":"Giuliani","year":"2019","journal-title":"Antioxidants"},{"key":"10.1016\/j.phrs.2024.107308_bib140","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1001\/jamaoncol.2017.5082","article-title":"Influence of treatment with tumor-treating fields on health-related quality of life of patients with newly diagnosed glioblastoma: a secondary analysis of a randomized clinical trial","volume":"4","author":"Taphoorn","year":"2018","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.phrs.2024.107308_bib141","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0125269","article-title":"Tumor treating fields perturb the localization of septins and cause aberrant mitotic exit","volume":"10","author":"Gera","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.phrs.2024.107308_bib142","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.1158\/0008-5472.CAN-22-0887","article-title":"The mechanisms of action of tumor treating fields","volume":"82","author":"Moser","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.phrs.2024.107308_bib143","article-title":"Electrotherapies for glioblastoma","volume":"8","author":"Jenkins","year":"2021","journal-title":"Adv. Sci. (Weinh. )"},{"key":"10.1016\/j.phrs.2024.107308_bib144","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1001\/jama.2017.18718","article-title":"Effect of tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma: a randomized clinical trial","volume":"318","author":"Stupp","year":"2017","journal-title":"Jama"},{"key":"10.1016\/j.phrs.2024.107308_bib145","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111810","article-title":"Progress and prospect in tumor treating fields treatment of glioblastoma","volume":"141","author":"Liu","year":"2021","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.phrs.2024.107308_bib146","doi-asserted-by":"crossref","DOI":"10.3390\/cells10030621","article-title":"Cancer stem cells: significance in origin, pathogenesis and treatment of glioblastoma","volume":"10","author":"Biserova","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.phrs.2024.107308_bib147","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23094602","article-title":"Glioblastoma stem cells-useful tools in the battle against cancer","volume":"23","author":"Rodriguez","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.phrs.2024.107308_bib148","doi-asserted-by":"crossref","first-page":"5862","DOI":"10.2174\/0929867325666180514113136","article-title":"Recent advances on glioblastoma multiforme and nano-drug carriers: a review","volume":"26","author":"Liao","year":"2019","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.phrs.2024.107308_bib149","doi-asserted-by":"crossref","unstructured":"Retraction: Glioma-associated cancer-initiating cells induce immunosuppression, Clinical cancer research: an official journal of the American Association for Cancer Research, 21 (2015) 2189.","DOI":"10.1158\/1078-0432.CCR-15-0266"},{"key":"10.1016\/j.phrs.2024.107308_bib150","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1471-2407-11-82","article-title":"Notch signaling contributes to the maintenance of both normal neural stem cells and patient-derived glioma stem cells","volume":"11","author":"Hu","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1016\/j.phrs.2024.107308_bib151","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/j.devcel.2022.06.006","article-title":"Interferon-\u03b3 resistance and immune evasion in glioma develop via Notch-regulated co-evolution of malignant and immune cells","volume":"57","author":"Parmigiani","year":"2022","journal-title":"Dev. Cell"},{"key":"10.1016\/j.phrs.2024.107308_bib152","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1007\/s11481-012-9359-y","article-title":"Wnt\/beta-catenin signaling in glioma","volume":"7","author":"Zhang","year":"2012","journal-title":"J. NeuroImmune Pharmacol.: Off. J. Soc. NeuroImmune Pharmacol."},{"key":"10.1016\/j.phrs.2024.107308_bib153","doi-asserted-by":"crossref","first-page":"617","DOI":"10.4155\/fmc-2018-0497","article-title":"State of the art of Smo antagonists for cancer therapy: advances in the target receptor and new ligand structures","volume":"11","author":"Espinosa-Bustos","year":"2019","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.phrs.2024.107308_bib154","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21030758","article-title":"Sonic Hedgehog Signaling in Organogenesis, Tumors, and Tumor Microenvironments","volume":"21","author":"Jeng","year":"2020","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.phrs.2024.107308_bib155","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23031353","article-title":"Wnt and PI3K\/Akt\/mTOR survival pathways as therapeutic targets in glioblastoma","volume":"23","author":"Barzegar Behrooz","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.phrs.2024.107308_bib156","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.bbrc.2013.03.021","article-title":"Cell surface Nestin is a biomarker for glioma stem cells","volume":"433","author":"Jin","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.phrs.2024.107308_bib157","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202202216","article-title":"The interaction between DNMT1 and high-mannose CD133 maintains the slow-cycling state and tumorigenic potential of glioma stem cell","volume":"9","author":"Wei","year":"2022","journal-title":"Adv. Sci."},{"key":"10.1016\/j.phrs.2024.107308_bib158","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1186\/s12885-021-08164-1","article-title":"V. Krajka-Ku\u017aniak, COXIBs and 2,5-dimethylcelecoxib counteract the hyperactivated Wnt\/\u03b2-catenin pathway and COX-2\/PGE2\/EP4 signaling in glioblastoma cells","volume":"21","author":"Majchrzak-Celi\u0144ska","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.phrs.2024.107308_bib159","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.2174\/1568026619666191112140939","article-title":"Feasibility of targeting glioblastoma stem cells: from concept to clinical trials","volume":"19","author":"Tarasov","year":"2019","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.phrs.2024.107308_bib160","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1016\/j.apsb.2020.11.023","article-title":"Evolution of blood-brain barrier in brain diseases and related systemic nanoscale brain-targeting drug delivery strategies","volume":"11","author":"Han","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.phrs.2024.107308_bib161","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drup.2015.02.002","article-title":"Overcoming the blood-brain tumor barrier for effective glioblastoma treatment","volume":"19","author":"van Tellingen","year":"2015","journal-title":"Drug Resist. Update.: Rev. Comment. Antimicrob. Anticancer Chemother."},{"key":"10.1016\/j.phrs.2024.107308_bib162","doi-asserted-by":"crossref","DOI":"10.3390\/cells11233761","article-title":"Novel nano-drug delivery system for brain tumor treatment","volume":"11","author":"Qiu","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.phrs.2024.107308_bib163","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jconrel.2021.07.031","article-title":"Does local drug delivery still hold therapeutic promise for brain cancer? A systematic review","volume":"337","author":"Bastiancich","year":"2021","journal-title":"J. Control Release"},{"key":"10.1016\/j.phrs.2024.107308_bib164","doi-asserted-by":"crossref","first-page":"6037","DOI":"10.1039\/D1BM00896J","article-title":"Local delivery to malignant brain tumors: potential biomaterial-based therapeutic\/adjuvant strategies","volume":"9","author":"Alghamdi","year":"2021","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.phrs.2024.107308_bib165","doi-asserted-by":"crossref","first-page":"43271","DOI":"10.1038\/srep43271","article-title":"Theranostic 3-Dimensional nano brain-implant for prolonged and localized treatment of recurrent glioma","volume":"7","author":"Ramachandran","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2024.107308_bib166","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1124\/jpet.119.258152","article-title":"Nose-to-Brain Delivery","volume":"370","author":"Wang","year":"2019","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.phrs.2024.107308_bib167","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.actbio.2022.11.013","article-title":"A simple self-assembly nanomicelle based on brain tumor-targeting peptide-mediated siRNA delivery for glioma immunotherapy via intranasal administration","volume":"155","author":"Tang","year":"2023","journal-title":"Acta Biomater."},{"key":"10.1016\/j.phrs.2024.107308_bib168","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jconrel.2011.05.008","article-title":"TRAIL and doxorubicin combination enhances anti-glioblastoma effect based on passive tumor targeting of liposomes","volume":"154","author":"Guo","year":"2011","journal-title":"J. Control Release"},{"key":"10.1016\/j.phrs.2024.107308_bib169","doi-asserted-by":"crossref","first-page":"8063","DOI":"10.1016\/j.biomaterials.2010.07.018","article-title":"Hydrogen bonding-enhanced micelle assemblies for drug delivery","volume":"31","author":"Kim","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.phrs.2024.107308_bib170","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11095-017-2324-y","article-title":"Chitosan engineered PAMAM dendrimers as nanoconstructs for the enhanced anti-cancer potential and improved in vivo brain pharmacokinetics of temozolomide","volume":"35","author":"Sharma","year":"2018","journal-title":"Pharm. Res."},{"key":"10.1016\/j.phrs.2024.107308_bib171","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.2174\/092986712800784702","article-title":"Drug-loaded nanocarriers: passive targeting and crossing of biological barriers","volume":"19","author":"Rabanel","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.phrs.2024.107308_bib172","first-page":"6387","article-title":"A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs","volume":"46","author":"Matsumura","year":"1986","journal-title":"Cancer Res."},{"key":"10.1016\/j.phrs.2024.107308_bib173","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.addr.2013.11.009","article-title":"Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology","volume":"66","author":"Bertrand","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.phrs.2024.107308_bib174","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2183\/pjab.88.53","article-title":"Vascular permeability in cancer and infection as related to macromolecular drug delivery, with emphasis on the EPR effect for tumor-selective drug targeting","volume":"88","author":"Maeda","year":"2012","journal-title":"Proc. Jpn. Acad. Ser. B, Phys. Biol. Sci."},{"key":"10.1016\/j.phrs.2024.107308_bib175","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jconrel.2011.06.001","article-title":"Targeted drug delivery to tumors: myths, reality and possibility","volume":"153","author":"Bae","year":"2011","journal-title":"J. Control Release"},{"key":"10.1016\/j.phrs.2024.107308_bib176","doi-asserted-by":"crossref","first-page":"9216","DOI":"10.1021\/nn203450p","article-title":"Nanoparticle-mediated measurement of target-drug binding in cancer cells","volume":"5","author":"Ullal","year":"2011","journal-title":"ACS Nano"},{"key":"10.1016\/j.phrs.2024.107308_bib177","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s40580-018-0168-8","article-title":"Therapeutic nanoplatforms and delivery strategies for neurological disorders","volume":"5","author":"Kang","year":"2018","journal-title":"Nano Converg."},{"key":"10.1016\/j.phrs.2024.107308_bib178","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s11481-016-9687-4","article-title":"Perspectives on dual targeting delivery systems for brain tumors","volume":"12","author":"Gao","year":"2017","journal-title":"J. NeuroImmune Pharmacol.: Off. J. Soc. NeuroImmune Pharmacol."},{"key":"10.1016\/j.phrs.2024.107308_bib179","doi-asserted-by":"crossref","first-page":"8727","DOI":"10.1021\/acsomega.0c05848","article-title":"Transferrin: biology and use in receptor-targeted nanotherapy of gliomas","volume":"6","author":"Koneru","year":"2021","journal-title":"ACS Omega"},{"key":"10.1016\/j.phrs.2024.107308_bib180","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22094556","article-title":"Transferrin-decorated niosomes with integrated InP\/ZnS quantum dots and magnetic iron oxide nanoparticles: dual targeting and imaging of glioma","volume":"22","author":"Ag Seleci","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2024.107308_bib181","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ijpharm.2016.06.127","article-title":"Brain tumor-targeted therapy by systemic delivery of siRNA with Transferrin receptor-mediated core-shell nanoparticles","volume":"510","author":"Wei","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.phrs.2024.107308_bib182","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.2147\/IJN.S123422","article-title":"Angiopep-2-conjugated poly(ethylene glycol)-co- poly(\u03b5-caprolactone) polymersomes for dual-targeting drug delivery to glioma in rats","volume":"12","author":"Lu","year":"2017","journal-title":"Int J. Nanomed."},{"key":"10.1016\/j.phrs.2024.107308_bib183","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13030503","article-title":"Theranostic Design of Angiopep-2 Conjugated Hyaluronic Acid Nanoparticles (Thera-ANG-cHANPs) for Dual Targeting and Boosted Imaging of Glioma Cells","volume":"13","author":"Costagliola di Polidoro","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.phrs.2024.107308_bib184","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drup.2018.03.001","article-title":"How the Warburg effect supports aggressiveness and drug resistance of cancer cells?","volume":"38","author":"Icard","year":"2018","journal-title":"Drug Resist. Update.: Rev. Comment. Antimicrob. Anticancer Chemother."},{"key":"10.1016\/j.phrs.2024.107308_bib185","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1021\/acschembio.8b00251","article-title":"Identification of compounds that decrease glioblastoma growth and glucose uptake in vitro","volume":"13","author":"Landis","year":"2018","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.phrs.2024.107308_bib186","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1002\/anie.201411226","article-title":"A D-peptide ligand of nicotine acetylcholine receptors for brain-targeted drug delivery","volume":"54","author":"Wei","year":"2015","journal-title":"Angew. Chem. Int Ed. Engl."},{"key":"10.1016\/j.phrs.2024.107308_bib187","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105336","article-title":"Choline and nicotine increase glioblastoma cell proliferation by binding and activating \u03b17- and \u03b19- containing nicotinic receptors","volume":"163","author":"Pucci","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2024.107308_bib188","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.jconrel.2020.08.010","article-title":"The influx\/efflux mechanisms of d-peptide ligand of nAChRs across the blood-brain barrier and its therapeutic value in treating glioma","volume":"327","author":"Han","year":"2020","journal-title":"J. Control Release"},{"key":"10.1016\/j.phrs.2024.107308_bib189","doi-asserted-by":"crossref","first-page":"24462","DOI":"10.1021\/acsami.7b05617","article-title":"EGFR\/EGFRvIII dual-targeting peptide-mediated drug delivery for enhanced glioma therapy","volume":"9","author":"Mao","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.phrs.2024.107308_bib190","doi-asserted-by":"crossref","first-page":"5115","DOI":"10.1016\/j.biomaterials.2012.03.058","article-title":"Precise glioma targeting of and penetration by aptamer and peptide dual-functioned nanoparticles","volume":"33","author":"Gao","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.phrs.2024.107308_bib191","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jconrel.2022.03.019","article-title":"Enhanced BBB and BBTB penetration and improved anti-glioma behavior of Bortezomib through dual-targeting nanostructured lipid carriers","volume":"345","author":"Farshbaf","year":"2022","journal-title":"J. Control Release"},{"key":"10.1016\/j.phrs.2024.107308_bib192","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1021\/mp500113p","article-title":"Angiopep-2 and activatable cell-penetrating peptide dual-functionalized nanoparticles for systemic glioma-targeting delivery","volume":"11","author":"Gao","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.phrs.2024.107308_bib193","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s12951-021-00866-9","article-title":"Construction of nanomaterials as contrast agents or probes for glioma imaging","volume":"19","author":"Zhao","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.phrs.2024.107308_bib194","doi-asserted-by":"crossref","first-page":"9290","DOI":"10.1039\/D3NR01018J","article-title":"Selection of an aggregation-caused quenching-based fluorescent tracer for imaging studies in nano drug delivery systems","volume":"15","author":"Ji","year":"2023","journal-title":"Nanoscale"},{"key":"10.1016\/j.phrs.2024.107308_bib195","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201900321","article-title":"Near-infrared-II molecular dyes for cancer imaging and surgery","volume":"31","author":"Zhu","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.phrs.2024.107308_bib196","doi-asserted-by":"crossref","first-page":"4280","DOI":"10.1021\/acs.molpharmaceut.0c00712","article-title":"Adsorptive-mediated endocytosis of sulfo-Cy5-labeled IgG causes aberrant igg processing by brain endothelial-like cells","volume":"17","author":"Ruano-Salguero","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.phrs.2024.107308_bib197","doi-asserted-by":"crossref","DOI":"10.3171\/2020.10.FOCUS20782","article-title":"Applications of indocyanine green in brain tumor surgery: review of clinical evidence and emerging technologies","volume":"50","author":"Teng","year":"2021","journal-title":"Neurosurg. Focus"},{"key":"10.1016\/j.phrs.2024.107308_bib198","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ejps.2019.04.021","article-title":"Reactive oxygen species and near-infrared light dual-responsive indocyanine green-loaded nanohybrids for overcoming tumour multidrug resistance","volume":"134","author":"Wang","year":"2019","journal-title":"Eur. J. Pharm. Sci.: Off. J. Eur. Fed. Pharm. Sci."},{"key":"10.1016\/j.phrs.2024.107308_bib199","doi-asserted-by":"crossref","first-page":"18327","DOI":"10.1021\/acsnano.1c07587","article-title":"A microfluidics-based scalable approach to generate extracellular vesicles with enhanced therapeutic microrna loading for intranasal delivery to mouse glioblastomas","volume":"15","author":"Wang","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.phrs.2024.107308_bib200","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1016\/j.apsb.2022.04.005","article-title":"A mitochondria-targeting lipid-small molecule hybrid nanoparticle for imaging and therapy in an orthotopic glioma model","volume":"12","author":"Tang","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.phrs.2024.107308_bib201","article-title":"Engineering macrophage exosome disguised biodegradable nanoplatform for enhanced sonodynamic therapy of glioblastoma","volume":"34","author":"Wu","year":"2022","journal-title":"Adv. Mater. (Deerfield Beach, Fla. )"},{"key":"10.1016\/j.phrs.2024.107308_bib202","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114830","article-title":"Luminescent quantum dots: Synthesis, optical properties, bioimaging and toxicity","volume":"197","author":"Sobhanan","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.phrs.2024.107308_bib203","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.addr.2012.09.036","article-title":"Quantum dots as a platform for nanoparticle drug delivery vehicle design","volume":"65","author":"Probst","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.phrs.2024.107308_bib204","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.ijbiomac.2022.04.207","article-title":"Carboxymethylcellulose biofunctionalized ternary quantum dots for subcellular-targeted brain cancer nanotheranostics","volume":"210","author":"Mansur","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.phrs.2024.107308_bib205","doi-asserted-by":"crossref","first-page":"6191","DOI":"10.1021\/acsnano.0c02249","article-title":"Albumin-based nanotheranostic probe with hypoxia alleviating potentiates synchronous multimodal imaging and phototherapy for glioma","volume":"14","author":"Yang","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.phrs.2024.107308_bib206","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104753","article-title":"Gold nanoparticles in glioma theranostics","volume":"156","author":"Norouzi","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2024.107308_bib207","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.jconrel.2021.05.042","article-title":"Magnetic nanoparticles for cancer theranostics: advances and prospects","volume":"335","author":"Li","year":"2021","journal-title":"J. Control Release"},{"key":"10.1016\/j.phrs.2024.107308_bib208","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1039\/D2BM00420H","article-title":"Targeted delivery of irinotecan and SLP2 shRNA with GRP-conjugated magnetic graphene oxide for glioblastoma treatment","volume":"10","author":"Chuang","year":"2022","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.phrs.2024.107308_bib209","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.biomaterials.2018.06.029","article-title":"NRP-1 targeted and cargo-loaded exosomes facilitate simultaneous imaging and therapy of glioma in vitro and in vivo","volume":"178","author":"Jia","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.phrs.2024.107308_bib210","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.apsb.2017.09.008","article-title":"Substance P-modified human serum albumin nanoparticles loaded with paclitaxel for targeted therapy of glioma","volume":"8","author":"Ruan","year":"2018","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.phrs.2024.107308_bib211","doi-asserted-by":"crossref","first-page":"9999","DOI":"10.1021\/acsnano.6b04268","article-title":"Blood-brain-barrier-penetrating albumin nanoparticles for biomimetic drug delivery via albumin-binding protein pathways for antiglioma therapy","volume":"10","author":"Lin","year":"2016","journal-title":"ACS Nano"},{"key":"10.1016\/j.phrs.2024.107308_bib212","doi-asserted-by":"crossref","first-page":"8838","DOI":"10.1021\/acsami.1c23907","article-title":"Anchoring group-mediated radiolabeling of inorganic nanoparticles\u2500a universal method for constructing nuclear medicine imaging nanoprobes","volume":"14","author":"Ge","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.phrs.2024.107308_bib213","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1021\/acs.bioconjchem.1c00121","article-title":"Synthesis and comparative in vivo evaluation of site-specifically labeled radioimmunoconjugates for DLL3-targeted immunoPET","volume":"32","author":"Sharma","year":"2021","journal-title":"Bioconjugate Chem."},{"key":"10.1016\/j.phrs.2024.107308_bib214","doi-asserted-by":"crossref","first-page":"422","DOI":"10.7150\/thno.68182","article-title":"Evans blue-modified radiolabeled fibroblast activation protein inhibitor as long-acting cancer therapeutics","volume":"12","author":"Wen","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.phrs.2024.107308_bib215","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12951-019-0462-6","article-title":"Chlorotoxin peptide-functionalized polyethylenimine-entrapped gold nanoparticles for glioma SPECT\/CT imaging and radionuclide therapy","volume":"17","author":"Zhao","year":"2019","journal-title":"J. Nanobiotechnology"},{"key":"10.1016\/j.phrs.2024.107308_bib216","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2967\/jnumed.108.060665","article-title":"Combined reporter gene PET and iron oxide MRI for monitoring survival and localization of transplanted cells in the rat heart","volume":"50","author":"Higuchi","year":"2009","journal-title":"J. Nucl. Med.: Off. Publ., Soc. Nucl. Med."},{"key":"10.1016\/j.phrs.2024.107308_bib217","doi-asserted-by":"crossref","first-page":"10991","DOI":"10.1021\/acsnano.9b02173","article-title":"Dual-modal imaging-guided precise tracking of bioorthogonally labeled mesenchymal stem cells in mouse brain stroke","volume":"13","author":"Lim","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.phrs.2024.107308_bib218","doi-asserted-by":"crossref","first-page":"12574","DOI":"10.1039\/D3NR01539D","article-title":"Sonoporation-assisted micelle delivery in subcutaneous glioma-bearing mice evaluated by PET\/fluorescent bi-modal imaging","volume":"15","author":"Porret","year":"2023","journal-title":"Nanoscale"},{"key":"10.1016\/j.phrs.2024.107308_bib219","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1186\/s12951-022-01610-7","article-title":"Overcoming the blood-brain barrier for the therapy of malignant brain tumor: current status and prospects of drug delivery approaches","volume":"20","author":"Mitusova","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.phrs.2024.107308_bib220","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1186\/s12951-021-01180-0","article-title":"Combined integrin \u03b1(v)\u03b2(3) and lactoferrin receptor targeted docetaxel liposomes enhance the brain targeting effect and anti-glioma effect","volume":"19","author":"Qi","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.phrs.2024.107308_bib221","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1002\/adma.201506086","article-title":"Cancer cell membrane-coated upconversion nanoprobes for highly specific tumor imaging","volume":"28","author":"Rao","year":"2016","journal-title":"Adv. Mater."},{"key":"10.1016\/j.phrs.2024.107308_bib222","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12123724","article-title":"Viral vectors as gene therapy agents for treatment of glioblastoma","volume":"12","author":"Mozhei","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.phrs.2024.107308_bib223","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1021\/acs.molpharmaceut.9b00104","article-title":"Exosomes as drug carriers for cancer therapy","volume":"16","author":"Pullan","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.phrs.2024.107308_bib224","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12255","article-title":"Specific anti-glioma targeted-delivery strategy of engineered small extracellular vesicles dual-functionalised by Angiopep-2 and TAT peptides","volume":"11","author":"Zhu","year":"2022","journal-title":"J. Extracell. vesicles"},{"key":"10.1016\/j.phrs.2024.107308_bib225","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114801","article-title":"Metal-organic frameworks (MOFs) as biomolecules drug delivery systems for anticancer purposes","volume":"244","author":"Coluccia","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.phrs.2024.107308_bib226","article-title":"Tailoring porous silicon for biomedical applications: from drug delivery to cancer immunotherapy","volume":"30","author":"Li","year":"2018","journal-title":"Adv. Mater."},{"key":"10.1016\/j.phrs.2024.107308_bib227","doi-asserted-by":"crossref","first-page":"5687","DOI":"10.1002\/smll.201500540","article-title":"Combined delivery of temozolomide and anti-miR221 PNA using mesoporous silica nanoparticles induces apoptosis in resistant glioma cells","volume":"11","author":"Bertucci","year":"2015","journal-title":"Small"},{"key":"10.1016\/j.phrs.2024.107308_bib228","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23031641","article-title":"Modernistic and emerging developments of nanotechnology in glioblastoma-targeted theranostic applications","volume":"23","author":"Lakshmi","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.phrs.2024.107308_bib229","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1055\/a-1296-7870","article-title":"Molecular targets and nanoparticulate systems designed for the improved therapeutic intervention in glioblastoma multiforme","volume":"71","author":"Akhter","year":"2021","journal-title":"Drug Res."},{"key":"10.1016\/j.phrs.2024.107308_bib230","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/978-1-0716-3222-2_4","article-title":"Protein cages and nanostructures constructed from protein nanobuilding blocks","volume":"2671","author":"Kobayashi","year":"2023","journal-title":"Methods Mol. Biol"},{"key":"10.1016\/j.phrs.2024.107308_bib231","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1007\/s13346-022-01245-z","article-title":"Transferrin-modified chitosan nanoparticles for targeted nose-to-brain delivery of proteins","volume":"13","author":"Gabold","year":"2023","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.phrs.2024.107308_bib232","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123459","article-title":"Application of hyaluronic acid-based nanoparticles for cancer combination therapy","volume":"646","author":"Yang","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.phrs.2024.107308_bib233","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23042034","article-title":"PLGA-based composites for various biomedical applications","volume":"23","author":"Rocha","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.phrs.2024.107308_bib234","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.biomaterials.2012.10.048","article-title":"F3 peptide-functionalized PEG-PLA nanoparticles co-administrated with tLyp-1 peptide for anti-glioma drug delivery","volume":"34","author":"Hu","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.phrs.2024.107308_bib235","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2021.766470","article-title":"A multifunctional AIE nanoprobe as a drug delivery bioimaging and cancer treatment system","volume":"9","author":"Hu","year":"2021","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.phrs.2024.107308_bib236","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12951-021-00896-3","article-title":"Protein nanoparticles in drug delivery: animal protein, plant proteins and protein cages, albumin nanoparticles","volume":"19","author":"Kianfar","year":"2021","journal-title":"J. Nanobiotechnology"},{"key":"10.1016\/j.phrs.2024.107308_bib237","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jconrel.2021.01.033","article-title":"Hyaluronic acid and albumin based nanoparticles for drug delivery","volume":"331","author":"Lei","year":"2021","journal-title":"J. Control. Release: Off. J. Control. Release Soc."},{"key":"10.1016\/j.phrs.2024.107308_bib238","doi-asserted-by":"crossref","first-page":"5687","DOI":"10.1038\/s41467-020-19225-7","article-title":"Systemic brain tumor delivery of synthetic protein nanoparticles for glioblastoma therapy","volume":"11","author":"Gregory","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2024.107308_bib239","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28041963","article-title":"Chitosan-based nanoparticles as effective drug delivery systems-a review","volume":"28","author":"Jafernik","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.phrs.2024.107308_bib240","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.124398","article-title":"Review: application of chitosan and its derivatives in medical materials","volume":"240","author":"Tang","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.phrs.2024.107308_bib241","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22179652","article-title":"Advances in chitosan-based nanoparticles for drug delivery","volume":"22","author":"Miku\u0161ov\u00e1","year":"2021","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.phrs.2024.107308_bib242","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/jbm.a.36827","article-title":"Sustained release of silibinin-loaded chitosan nanoparticle induced apoptosis in glioma cells","volume":"108","author":"Alipour","year":"2020","journal-title":"J. Biomed. Mater. Res A"},{"key":"10.1016\/j.phrs.2024.107308_bib243","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1080\/21691401.2022.2092123","article-title":"MicroRNA-219 loaded chitosan nanoparticles for treatment of glioblastoma","volume":"50","author":"Alswailem","year":"2022","journal-title":"Artif. Cells, Nanomed., Biotechnol."},{"key":"10.1016\/j.phrs.2024.107308_bib244","article-title":"Nano-chitosan: a novel material for glioblastoma treatment","volume":"104","author":"Chopra","year":"2022","journal-title":"Int. J. Surg. (Lond., Engl. )"},{"key":"10.1016\/j.phrs.2024.107308_bib245","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ccell.2020.04.017","article-title":"Targeting FTO suppresses cancer stem cell maintenance and immune evasion","volume":"38","author":"Su","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.phrs.2024.107308_bib246","doi-asserted-by":"crossref","first-page":"5381","DOI":"10.2147\/IJN.S117210","article-title":"Getting into the brain: liposome-based strategies for effective drug delivery across the blood-brain barrier","volume":"11","author":"Vieira","year":"2016","journal-title":"Int J. Nanomed."},{"key":"10.1016\/j.phrs.2024.107308_bib247","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114281","article-title":"pH-redox responsive cascade-targeted liposomes to intelligently deliver doxorubicin prodrugs and lonidamine for glioma","volume":"235","author":"Zhao","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.phrs.2024.107308_bib248","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1038\/s41467-018-05384-1","article-title":"Enhanced immunocompatibility of ligand-targeted liposomes by attenuating natural IgM absorption","volume":"9","author":"Guan","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2024.107308_bib249","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1038\/s41467-019-11593-z","article-title":"Brain-targeted drug delivery by manipulating protein corona functions","volume":"10","author":"Zhang","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2024.107308_bib250","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jconrel.2019.11.005","article-title":"Non-immunogenic, low-toxicity and effective glioma targeting MTI-31 liposomes","volume":"316","author":"Wang","year":"2019","journal-title":"J. Control Release"},{"key":"10.1016\/j.phrs.2024.107308_bib251","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1021\/acs.nanolett.9b04683","article-title":"Charge conversional biomimetic nanocomplexes as a multifunctional platform for boosting orthotopic glioblastoma RNAi therapy","volume":"20","author":"Liu","year":"2020","journal-title":"Nano Lett."},{"key":"10.1016\/j.phrs.2024.107308_bib252","article-title":"Neutrophil delivered hollow titania covered persistent luminescent nanosensitizer for ultrosound augmented chemo\/immuno glioblastoma therapy","volume":"8","author":"Li","year":"2021","journal-title":"Adv. Sci. (Weinh., Baden. -Wurtt., Ger. )"},{"key":"10.1016\/j.phrs.2024.107308_bib253","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119666","article-title":"An iRGD-conjugated prodrug micelle with blood-brain-barrier penetrability for anti-glioma therapy","volume":"230","author":"Lu","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.phrs.2024.107308_bib254","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jconrel.2019.11.011","article-title":"Sequential depletion of myeloid-derived suppressor cells and tumor cells with a dual-pH-sensitive conjugated micelle system for cancer chemoimmunotherapy","volume":"317","author":"Wan","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.phrs.2024.107308_bib255","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.1021\/acs.nanolett.3c00449","article-title":"Role of micelle size in cell transcytosis-based tumor extravasation, infiltration, and treatment efficacy","volume":"23","author":"Fan","year":"2023","journal-title":"Nano Lett."},{"key":"10.1016\/j.phrs.2024.107308_bib256","doi-asserted-by":"crossref","first-page":"11779","DOI":"10.1021\/acs.analchem.0c01895","article-title":"Self-assembled mRNA-responsive DNA nanosphere for bioimaging and cancer therapy in drug-resistant cells","volume":"92","author":"Jiang","year":"2020","journal-title":"Anal. Chem."},{"key":"10.1016\/j.phrs.2024.107308_bib257","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1021\/acs.nanolett.3c04031","article-title":"Au nanorods activated the Zn\/Ce composites with cancer cell specific cytotoxicity for enhanced chemodynamic therapy","volume":"24","author":"Feng","year":"2023","journal-title":"Nano Lett."},{"key":"10.1016\/j.phrs.2024.107308_bib258","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-021-01162-2","article-title":"A molybdenum oxide-based degradable nanosheet for combined chemo-photothermal therapy to improve tumor immunosuppression and suppress distant tumors and lung metastases","volume":"19","author":"Qiu","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.phrs.2024.107308_bib259","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.2217\/nnm-2018-0017","article-title":"The potential of biomimetic nanoparticles for tumor-targeted drug delivery","volume":"13","author":"Li","year":"2018","journal-title":"Nanomedicine"},{"key":"10.1016\/j.phrs.2024.107308_bib260","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1021\/acsami.6b14450","article-title":"Erythrocyte membrane-coated upconversion nanoparticles with minimal protein adsorption for enhanced tumor imaging","volume":"9","author":"Rao","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.phrs.2024.107308_bib261","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ejpb.2022.07.009","article-title":"Blood cell-based drug delivery systems: a biomimetic platform for antibacterial therapy","volume":"177","author":"Rong","year":"2022","journal-title":"Eur. J. Pharm. Biopharm.: Off. J. Arb. fur Pharm. Verfahr. e. V."},{"key":"10.1016\/j.phrs.2024.107308_bib262","article-title":"White blood cell membrane-coated nanoparticles: recent development and medical applications","volume":"11","author":"Wang","year":"2022","journal-title":"Adv. Health Mater."},{"key":"10.1016\/j.phrs.2024.107308_bib263","doi-asserted-by":"crossref","first-page":"32","DOI":"10.20892\/j.issn.2095-3941.2019.0372","article-title":"Targeting and exploitation of tumor-associated neutrophils to enhance immunotherapy and drug delivery for cancer treatment","volume":"17","author":"Zhang","year":"2020","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.phrs.2024.107308_bib264","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201706245","article-title":"Neutrophil-based drug delivery systems","volume":"30","author":"Chu","year":"2018","journal-title":"Adv. Mater."},{"key":"10.1016\/j.phrs.2024.107308_bib265","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216106","article-title":"Homologous cancer cell membrane-camouflaged nanoparticles target drug delivery and enhance the chemotherapy efficacy of hepatocellular carcinoma","volume":"558","author":"Wu","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phrs.2024.107308_bib266","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.jcis.2023.08.109","article-title":"Cancer cell membrane biomimetic nanosystem for homologous targeted dual-mode imaging and combined therapy","volume":"652","author":"Li","year":"2023","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.phrs.2024.107308_bib267","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122026","article-title":"Tumor microenvironment targeting system for glioma treatment via fusion cell membrane coating nanotechnology","volume":"295","author":"Ma","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.phrs.2024.107308_bib268","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120282","article-title":"Overcoming the delivery problem for therapeutic genome editing: Current status and perspective of non-viral methods","volume":"258","author":"Mashel","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.phrs.2024.107308_bib269","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.867013","article-title":"The Past, Present, and Future of Non-Viral CAR T Cells","volume":"13","author":"Moretti","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2024.107308_bib270","doi-asserted-by":"crossref","DOI":"10.3171\/2020.11.FOCUS20859","article-title":"Using viral vectors to deliver local immunotherapy to glioblastoma","volume":"50","author":"Haddad","year":"2021","journal-title":"Neurosurg. Focus"},{"key":"10.1016\/j.phrs.2024.107308_bib271","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.biomaterials.2015.11.066","article-title":"Development of next generation adeno-associated viral vectors capable of selective tropism and efficient gene delivery","volume":"80","author":"Zhang","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.phrs.2024.107308_bib272","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120784","article-title":"Inflammatory tumor microenvironment responsive neutrophil exosomes-based drug delivery system for targeted glioma therapy","volume":"273","author":"Wang","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.phrs.2024.107308_bib273","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2022.112505","article-title":"Tumor-derived exosomes reversing TMZ resistance by synergistic drug delivery for glioma-targeting treatment","volume":"215","author":"Wang","year":"2022","journal-title":"Colloids Surf. B, Biointerfaces"},{"key":"10.1016\/j.phrs.2024.107308_bib274","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1089\/hum.2015.025","article-title":"Adeno-associated virus at 50: a golden anniversary of discovery, research, and gene therapy success--a personal perspective","volume":"26","author":"Hastie","year":"2015","journal-title":"Hum. gene Ther."},{"key":"10.1016\/j.phrs.2024.107308_bib275","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1073\/pnas.56.1.86","article-title":"Nucleic acid from an adeno-associated virus: chemical and physical studies","volume":"56","author":"Rose","year":"1966","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phrs.2024.107308_bib276","doi-asserted-by":"crossref","first-page":"10220","DOI":"10.1073\/pnas.1001673107","article-title":"A viral assembly factor promotes AAV2 capsid formation in the nucleolus","volume":"107","author":"Sonntag","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phrs.2024.107308_bib277","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF02253246","article-title":"Adeno-associated virus-based vectors in gene therapy","volume":"7","author":"Tal","year":"2000","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.phrs.2024.107308_bib278","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.3390\/ijms15034393","article-title":"Intratumoral decorin gene delivery by AAV vector inhibits brain glioblastomas and prolongs survival of animals by inducing cell differentiation","volume":"15","author":"Ma","year":"2014","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.phrs.2024.107308_bib279","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1089\/104303402753812511","article-title":"Adeno-associated viral vectors penetrate human solid tumor tissue in vivo more effectively than adenoviral vectors","volume":"13","author":"Enger","year":"2002","journal-title":"Hum. gene Ther."},{"key":"10.1016\/j.phrs.2024.107308_bib280","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121949","article-title":"Exosomes based strategies for brain drug delivery","volume":"293","author":"Rehman","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.phrs.2024.107308_bib281","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/aps.2017.12","article-title":"Engineering exosomes as refined biological nanoplatforms for drug delivery","volume":"38","author":"Luan","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.phrs.2024.107308_bib282","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1016\/j.apsb.2021.01.001","article-title":"The biology, function, and applications of exosomes in cancer","volume":"11","author":"Liu","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.phrs.2024.107308_bib283","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201904040","article-title":"Exosomes and nanoengineering: a match made for precision therapeutics","volume":"32","author":"Tran","year":"2020","journal-title":"Adv. Mater."},{"key":"10.1016\/j.phrs.2024.107308_bib284","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nbt.1807","article-title":"Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes","volume":"29","author":"Alvarez-Erviti","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.phrs.2024.107308_bib285","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.1002\/anie.201511063","article-title":"A solvent-free hot-pressing method for preparing metal-organic-framework coatings","volume":"55","author":"Chen","year":"2016","journal-title":"Angew. Chem. Int Ed. Engl."},{"key":"10.1016\/j.phrs.2024.107308_bib286","article-title":"Metal-organic frameworks and their composites for environmental applications","volume":"9","author":"Zhang","year":"2022","journal-title":"Adv. Sci."},{"key":"10.1016\/j.phrs.2024.107308_bib287","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201707634","article-title":"Nanoscale metal-organic frameworks for therapeutic, imaging, and sensing applications","volume":"30","author":"Lu","year":"2018","journal-title":"Adv. Mater."},{"key":"10.1016\/j.phrs.2024.107308_bib288","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201905227","article-title":"Advanced photoresponsive materials using the metal-organic framework approach","volume":"32","author":"Haldar","year":"2020","journal-title":"Adv. Mater."},{"key":"10.1016\/j.phrs.2024.107308_bib289","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201606134","article-title":"Metal-organic framework (MOF)-based drug\/cargo delivery and cancer therapy","volume":"29","author":"Wu","year":"2017","journal-title":"Adv. Mater."},{"key":"10.1016\/j.phrs.2024.107308_bib290","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2023.167295","article-title":"Functionalization strategies of metal-organic frameworks for biomedical applications and treatment of emerging pollutants: a review","volume":"906","author":"Nguyen","year":"2024","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.phrs.2024.107308_bib291","doi-asserted-by":"crossref","first-page":"16982","DOI":"10.1002\/anie.202007474","article-title":"Rabies virus-inspired metal-organic frameworks (MOFs) for targeted imaging and chemotherapy of glioma","volume":"59","author":"Qiao","year":"2020","journal-title":"Angew. Chem."},{"key":"10.1016\/j.phrs.2024.107308_bib292","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2022.101558","article-title":"Multifunctional high boron content MOFs nano-co-crystals for precise boron neutron capture therapy for brain glioma in situ","volume":"45","author":"Wang","year":"2022","journal-title":"Nano Today"},{"key":"10.1016\/j.phrs.2024.107308_bib293","article-title":"Metal-organic frameworks for biomedical applications","volume":"16","author":"Yang","year":"2020","journal-title":"Small"},{"key":"10.1016\/j.phrs.2024.107308_bib294","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119735","article-title":"Hyaluronic acid-drug conjugate modified core-shell MOFs as pH responsive nanoplatform for multimodal therapy of glioblastoma","volume":"588","author":"Pandey","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.phrs.2024.107308_bib295","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201907035","article-title":"Nanoarchitectured structure and surface biofunctionality of mesoporous silica nanoparticles","volume":"32","author":"Kankala","year":"2020","journal-title":"Adv. Mater"},{"key":"10.1016\/j.phrs.2024.107308_bib296","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12951-022-01315-x","article-title":"Nanoarchitectured prototypes of mesoporous silica nanoparticles for innovative biomedical applications","volume":"20","author":"Kankala","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.phrs.2024.107308_bib297","doi-asserted-by":"crossref","DOI":"10.1016\/j.mseb.2020.114835","article-title":"How to design nanoporous silica nanoparticles in regulating drug delivery: surface modification and porous control","volume":"263","author":"Zhang","year":"2021","journal-title":"Mater. Sci. Eng. B-Adv. Funct. Solid-State Mater."},{"key":"10.1016\/j.phrs.2024.107308_bib298","doi-asserted-by":"crossref","first-page":"9750","DOI":"10.1039\/D0CC03740K","article-title":"Porous materials as carriers of gasotransmitters towards gas biology and therapeutic applications","volume":"56","author":"Carn\u00e9-S\u00e1nchez","year":"2020","journal-title":"Chem. Commun."},{"key":"10.1016\/j.phrs.2024.107308_bib299","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41392-023-01654-7","article-title":"Multifunctional mesoporous silica nanoparticles for biomedical applications","volume":"8","author":"Xu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.phrs.2024.107308_bib300","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jconrel.2017.07.047","article-title":"Mesoporous silica materials: from physico-chemical properties to enhanced dissolution of poorly water-soluble drugs","volume":"262","author":"Maleki","year":"2017","journal-title":"J. Control Release"},{"key":"10.1016\/j.phrs.2024.107308_bib301","doi-asserted-by":"crossref","first-page":"3779","DOI":"10.1002\/adma.201200653","article-title":"Hybrid nanoparticles for detection and treatment of cancer","volume":"24","author":"Sailor","year":"2012","journal-title":"Adv. Mater."},{"key":"10.1016\/j.phrs.2024.107308_bib302","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202201884","article-title":"Mesoporous silica nanoparticles-based nanoplatforms: basic construction, current state, and emerging applications in anticancer therapeutics","volume":"12","author":"Feng","year":"2023","journal-title":"Adv. Health Mater."},{"key":"10.1016\/j.phrs.2024.107308_bib303","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s13346-021-00935-4","article-title":"Exploring the role of mesoporous silica nanoparticle in the development of novel drug delivery systems","volume":"12","author":"Stephen","year":"2022","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.phrs.2024.107308_bib304","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/adma.201104763","article-title":"Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery","volume":"24","author":"Tang","year":"2012","journal-title":"Adv. Mater."},{"key":"10.1016\/j.phrs.2024.107308_bib305","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1080\/17425247.2016.1229298","article-title":"Recent advances in porous nanoparticles for drug delivery in antitumoral applications: inorganic nanoparticles and nanoscale metal-organic frameworks","volume":"14","author":"Baeza","year":"2017","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.phrs.2024.107308_bib306","article-title":"Exploiting recent trends for the synthesis and surface functionalization of mesoporous silica nanoparticles towards biomedical applications","volume":"4","author":"Siddiqui","year":"2022","journal-title":"Int. J. Pharm.: X"},{"key":"10.1016\/j.phrs.2024.107308_bib307","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/wnan.132","article-title":"Drug delivery from structured porous inorganic materials","volume":"4","author":"Arruebo","year":"2012","journal-title":"Wiley Inter. Rev. Nanomed. Nanobiotechnol"},{"key":"10.1016\/j.phrs.2024.107308_bib308","doi-asserted-by":"crossref","first-page":"3724","DOI":"10.1021\/nl801976m","article-title":"Structurally ordered mesoporous carbon nanoparticles as transmembrane delivery vehicle in human cancer cells","volume":"8","author":"Kim","year":"2008","journal-title":"Nano Lett."},{"key":"10.1016\/j.phrs.2024.107308_bib309","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1080\/10717544.2017.1399300","article-title":"Mesoporous carbon nanomaterials in drug delivery and biomedical application","volume":"24","author":"Zhao","year":"2017","journal-title":"Drug Deliv."},{"key":"10.1016\/j.phrs.2024.107308_bib310","article-title":"Combination glioma therapy mediated by a dual-targeted delivery system constructed using OMCN-PEG-Pep22\/DOX","volume":"14","author":"Qian","year":"2018","journal-title":"Small"},{"key":"10.1016\/j.phrs.2024.107308_bib311","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1002\/anie.201107144","article-title":"Well-defined, reversible boronate crosslinked nanocarriers for targeted drug delivery in response to acidic pH values and cis-diols","volume":"51","author":"Li","year":"2012","journal-title":"Angew. Chem. Int Ed. Engl."},{"key":"10.1016\/j.phrs.2024.107308_bib312","article-title":"Stimulus-responsive nanomedicines for disease diagnosis and treatment","volume":"21","author":"Liu","year":"2020","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.phrs.2024.107308_bib313","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12951-022-01364-2","article-title":"Nanocarrier cancer therapeutics with functional stimuli-responsive mechanisms","volume":"20","author":"Kaushik","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.phrs.2024.107308_bib314","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.biotechadv.2013.11.009","article-title":"pH-sensitive nano-systems for drug delivery in cancer therapy","volume":"32","author":"Liu","year":"2014","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.phrs.2024.107308_bib315","doi-asserted-by":"crossref","first-page":"526","DOI":"10.7150\/thno.30779","article-title":"Stimuli-responsive nanotheranostics for real-time monitoring drug release by photoacoustic imaging","volume":"9","author":"Yang","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.phrs.2024.107308_bib316","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1021\/acsnano.1c08120","article-title":"Smart nanomedicine to enable crossing blood-brain barrier delivery of checkpoint blockade antibody for immunotherapy of glioma","volume":"16","author":"Wang","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.phrs.2024.107308_bib317","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jconrel.2012.06.028","article-title":"Fabrication of magnetic nanoparticles with controllable drug loading and release through a simple assembly approach","volume":"162","author":"Fang","year":"2012","journal-title":"J. Control. Release: Off. J. Control. Release Soc."},{"key":"10.1016\/j.phrs.2024.107308_bib318","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14020422","article-title":"A nanosized codelivery system based on intracellular stimuli-triggered dual-drug release for multilevel chemotherapy amplification in drug-resistant breast cancer","volume":"14","author":"Guo","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.phrs.2024.107308_bib319","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1016\/j.biomaterials.2011.12.030","article-title":"Multifunctional unimolecular micelles for cancer-targeted drug delivery and positron emission tomography imaging","volume":"33","author":"Xiao","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.phrs.2024.107308_bib320","doi-asserted-by":"crossref","first-page":"5262","DOI":"10.1016\/j.biomaterials.2013.03.035","article-title":"Intracellular release of doxorubicin from core-crosslinked polypeptide micelles triggered by both pH and reduction conditions","volume":"34","author":"Wu","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.phrs.2024.107308_bib321","doi-asserted-by":"crossref","first-page":"7743","DOI":"10.1039\/C4CC01429D","article-title":"Smart drug delivery systems: from fundamentals to the clinic","volume":"50","author":"Alvarez-Lorenzo","year":"2014","journal-title":"Chem. Commun."},{"key":"10.1016\/j.phrs.2024.107308_bib322","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1016\/j.biomaterials.2009.01.026","article-title":"Reduction-sensitive polymers and bioconjugates for biomedical applications","volume":"30","author":"Meng","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.phrs.2024.107308_bib323","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.addr.2018.05.007","article-title":"Reduction-sensitive polymeric nanomedicines: An emerging multifunctional platform for targeted cancer therapy","volume":"132","author":"Sun","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.phrs.2024.107308_bib324","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.apsb.2021.05.003","article-title":"GSH-sensitive polymeric prodrug: synthesis and loading with photosensitizers as nanoscale chemo-photodynamic anti-cancer nanomedicine","volume":"12","author":"Luo","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.phrs.2024.107308_bib325","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/adhm.201400299","article-title":"Biocompatible reactive oxygen species (ROS)-responsive nanoparticles as superior drug delivery vehicles","volume":"4","author":"Zhang","year":"2015","journal-title":"Adv. Health Mater."},{"key":"10.1016\/j.phrs.2024.107308_bib326","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201705054","article-title":"Traceable nanoparticles with dual targeting and ROS response for RNAi-based immunochemotherapy of intracranial glioblastoma treatment","volume":"30","author":"Qiao","year":"2018","journal-title":"Adv. Mater."},{"key":"10.1016\/j.phrs.2024.107308_bib327","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1039\/C6BM00960C","article-title":"Enhanced bioreduction-responsive biodegradable diselenide-containing poly(ester urethane) nanocarriers","volume":"5","author":"Wei","year":"2017","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.phrs.2024.107308_bib328","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.actbio.2021.05.023","article-title":"Reactive oxygen species-sensitive polymeric nanocarriers for synergistic cancer therapy","volume":"130","author":"Cao","year":"2021","journal-title":"Acta Biomater."},{"key":"10.1016\/j.phrs.2024.107308_bib329","article-title":"ROS-responsive blended nanoparticles: cascade-amplifying synergistic effects of sonochemotherapy with on-demand boosted drug release during SDT process","volume":"8","author":"Wu","year":"2019","journal-title":"Adv. Health Mater."},{"key":"10.1016\/j.phrs.2024.107308_bib330","doi-asserted-by":"crossref","first-page":"10941","DOI":"10.1039\/D2CC03777G","article-title":"SIWV tetrapeptide and ROS-responsive prodrug conjugate for advanced glioblastoma therapy","volume":"58","author":"Park","year":"2022","journal-title":"Chem. Commun. (Camb., Engl. )"},{"key":"10.1016\/j.phrs.2024.107308_bib331","doi-asserted-by":"crossref","first-page":"18301","DOI":"10.1021\/acsami.0c00650","article-title":"ROS-responsive nanoparticles formed from RGD-epothilone B conjugate for targeted cancer therapy","volume":"12","author":"Xia","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.phrs.2024.107308_bib332","doi-asserted-by":"crossref","DOI":"10.3390\/polym14040687","article-title":"Applications of the ROS-responsive thioketal linker for the production of smart nanomedicines","volume":"14","author":"Rinaldi","year":"2022","journal-title":"Polymers"},{"key":"10.1016\/j.phrs.2024.107308_bib333","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.addr.2012.01.002","article-title":"Enzyme-responsive nanoparticles for drug release and diagnostics","volume":"64","author":"de la Rica","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.phrs.2024.107308_bib334","doi-asserted-by":"crossref","first-page":"5933","DOI":"10.1039\/c2cs35103j","article-title":"Enzyme-responsive polymeric assemblies, nanoparticles and hydrogels","volume":"41","author":"Hu","year":"2012","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.phrs.2024.107308_bib335","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jconrel.2019.07.004","article-title":"Enzyme responsive drug delivery systems in cancer treatment","volume":"308","author":"Shahriari","year":"2019","journal-title":"J. Control Release"},{"key":"10.1016\/j.phrs.2024.107308_bib336","doi-asserted-by":"crossref","first-page":"30433","DOI":"10.1074\/jbc.R800035200","article-title":"Proteases: multifunctional enzymes in life and disease","volume":"283","author":"L\u00f3pez-Ot\u00edn","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2024.107308_bib337","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.7150\/thno.22679","article-title":"Stimuli-responsive nanomedicines for overcoming cancer multidrug resistance","volume":"8","author":"Zhou","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.phrs.2024.107308_bib338","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s12951-021-00943-z","article-title":"Multi-responsive nanofibers composite gel for local drug delivery to inhibit recurrence of glioma after operation","volume":"19","author":"Zhu","year":"2021","journal-title":"J. Nanobiotechnology"},{"key":"10.1016\/j.phrs.2024.107308_bib339","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1021\/acsnano.9b08285","article-title":"Cytosolic NQO1 enzyme-activated near-infrared fluorescence imaging and photodynamic therapy with polymeric vesicles","volume":"14","author":"Yao","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.phrs.2024.107308_bib340","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101950","article-title":"The diverse functionality of NQO1 and its roles in redox control","volume":"41","author":"Ross","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.phrs.2024.107308_bib341","doi-asserted-by":"crossref","first-page":"6983","DOI":"10.1021\/acs.jmedchem.8b00124","article-title":"NAD(P)H: quinone oxidoreductase 1 (NQO1) as a therapeutic and diagnostic target in cancer","volume":"61","author":"Zhang","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.phrs.2024.107308_bib342","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1021\/ar500217w","article-title":"Photocontrolled nanoparticle delivery systems for biomedical applications","volume":"47","author":"Bansal","year":"2014","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.phrs.2024.107308_bib343","doi-asserted-by":"crossref","first-page":"4900","DOI":"10.1002\/anie.200600387","article-title":"Biologically active molecules with a \"light switch\"","volume":"45","author":"Mayer","year":"2006","journal-title":"Angew. Chem. Int Ed. Engl."},{"key":"10.1016\/j.phrs.2024.107308_bib344","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1039\/B901255A","article-title":"Chemistry and biological applications of photo-labile organic molecules","volume":"39","author":"Yu","year":"2010","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.phrs.2024.107308_bib345","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12951-020-00642-1","article-title":"Photo-responsive degradable hollow mesoporous organosilica nanoplatforms for drug delivery","volume":"18","author":"Fan","year":"2020","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.phrs.2024.107308_bib346","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.125826","article-title":"Polydopamine-containing nano-systems for cancer multi-mode diagnoses and therapies: a review","volume":"247","author":"Li","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.phrs.2024.107308_bib347","article-title":"Polydopamine-coated i-motif DNA\/Gold nanoplatforms for synergistic photothermal-chemotherapy","volume":"18","author":"Chen","year":"2023","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.phrs.2024.107308_bib348","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jconrel.2023.09.043","article-title":"The innovative design of a delivery and real-time tracer system for anti-encephalitis drugs that can penetrate the blood-brain barrier","volume":"363","author":"Wang","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.phrs.2024.107308_bib349","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2019.115045","article-title":"Controlling the porous structure of alginate ferrogel for anticancer drug delivery under magnetic stimulation","volume":"223","author":"Kim","year":"2019","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.phrs.2024.107308_bib350","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.jconrel.2022.03.050","article-title":"In situ targeting nanoparticles-hydrogel hybrid system for combined chemo-immunotherapy of glioma","volume":"345","author":"Wang","year":"2022","journal-title":"J. Control. Release: Off. J. Control. Release Soc."},{"key":"10.1016\/j.phrs.2024.107308_bib351","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.msec.2017.02.016","article-title":"Controlled co-release of doxorubicin and reactive oxygen species for synergistic therapy by NIR remote-triggered nanoimpellers","volume":"74","author":"Hou","year":"2017","journal-title":"Mater. Sci. Eng. C., Mater. Biol. Appl."},{"key":"10.1016\/j.phrs.2024.107308_bib352","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.actbio.2022.11.053","article-title":"Acidity\/carbon dioxide-sensitive triblock polymer-grafted photoactivated vesicles for programmed release of chemotherapeutic drugs against glioblastoma","volume":"157","author":"Younis","year":"2023","journal-title":"Acta Biomater."},{"key":"10.1016\/j.phrs.2024.107308_bib353","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jconrel.2022.11.021","article-title":"Ultrasound nanotheranostics: toward precision medicine","volume":"353","author":"Qin","year":"2023","journal-title":"J. Control Release"},{"key":"10.1016\/j.phrs.2024.107308_bib354","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1016\/j.biomaterials.2013.11.057","article-title":"Stimuli-responsive biodegradable poly(methacrylic acid) based nanocapsules for ultrasound traced and triggered drug delivery system","volume":"35","author":"Yang","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.phrs.2024.107308_bib355","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23092210","article-title":"Oxygen-carrying micro\/nanobubbles: composition,\u00a0synthesis techniques and potential prospects in photo-triggered theranostics","volume":"23","author":"Khan","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.phrs.2024.107308_bib356","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113042","article-title":"Ultrasound-triggered drug delivery for glioma therapy through gambogic acid-loaded nanobubble-microbubble complexes","volume":"150","author":"Wang","year":"2022","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.phrs.2024.107308_bib357","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.7150\/thno.38069","article-title":"Stimuli-responsive nanocarriers for drug delivery, tumor imaging, therapy and theranostics","volume":"10","author":"Mi","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.phrs.2024.107308_bib358","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121966","article-title":"Stimuli-responsive hybrid metal nanocomposite - a promising technology for effective anticancer therapy","volume":"624","author":"Dutta","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.phrs.2024.107308_bib359","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.msec.2014.05.050","article-title":"Stimuli-responsive polymers for anti-cancer drug delivery","volume":"45","author":"Cheng","year":"2014","journal-title":"Mater. Sci. Eng. C., Mater. Biol. Appl."},{"key":"10.1016\/j.phrs.2024.107308_bib360","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.biomaterials.2015.09.018","article-title":"Nanoscale theranostics for physical stimulus-responsive cancer therapies","volume":"73","author":"Chen","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.phrs.2024.107308_bib361","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jconrel.2017.04.028","article-title":"Light\/magnetic hyperthermia triggered drug released from multi-functional thermo-sensitive magnetoliposomes for precise cancer synergetic theranostics","volume":"272","author":"Guo","year":"2018","journal-title":"J. Control Release"},{"key":"10.1016\/j.phrs.2024.107308_bib362","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1021\/acs.biomac.1c00314","article-title":"Angiopep-2-modified carboxymethyl chitosan-based pH\/reduction dual-stimuli-responsive nanogels for enhanced targeting glioblastoma","volume":"22","author":"Song","year":"2021","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.phrs.2024.107308_bib363","doi-asserted-by":"crossref","first-page":"6570","DOI":"10.1016\/j.biomaterials.2012.05.062","article-title":"Redox\/pH dual stimuli-responsive biodegradable nanohydrogels with varying responses to dithiothreitol and glutathione for controlled drug release","volume":"33","author":"Pan","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.phrs.2024.107308_bib364","article-title":"Biodegradable micelles for NIR\/GSH-triggered chemophototherapy of cancer","volume":"9","author":"Zhang","year":"2019","journal-title":"Nanomaterials"},{"key":"10.1016\/j.phrs.2024.107308_bib365","doi-asserted-by":"crossref","first-page":"11455","DOI":"10.1021\/acsnano.5b05575","article-title":"Self-targeting fluorescent carbon dots for diagnosis of brain cancer cells","volume":"9","author":"Zheng","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.phrs.2024.107308_bib366","article-title":"Targeted delivery of chemo-sonodynamic therapy via brain targeting, glutathione-consumable polymeric nanoparticles for effective brain cancer treatment","volume":"9","author":"Wu","year":"2022","journal-title":"Adv. Sci. (Weinh., Baden. -Wurtt., Ger. )"},{"key":"10.1016\/j.phrs.2024.107308_bib367","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1002\/ijc.22709","article-title":"Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles","volume":"120","author":"Liu","year":"2007","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.phrs.2024.107308_bib368","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1038\/s41416-021-01515-6","article-title":"IL-10 in glioma","volume":"125","author":"Widodo","year":"2021","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.phrs.2024.107308_bib369","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s11060-010-0158-0","article-title":"IL-6 promotion of glioblastoma cell invasion and angiogenesis in U251 and T98G cell lines","volume":"100","author":"Liu","year":"2010","journal-title":"J. neuro-Oncol."},{"key":"10.1016\/j.phrs.2024.107308_bib370","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1038\/s41388-018-0182-7","article-title":"Astrocyte-derived CCL20 reinforces HIF-1-mediated hypoxic responses in glioblastoma by stimulating the CCR6-NF-\u03baB signaling pathway","volume":"37","author":"Jin","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.phrs.2024.107308_bib371","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/neuonc\/noab212","article-title":"TGF-\u03b2 promotes microtube formation in glioblastoma through thrombospondin 1","volume":"24","author":"Joseph","year":"2022","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.phrs.2024.107308_bib372","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174216","article-title":"Regulatory effects of IL-1\u03b2 in the interaction of GBM and tumor-associated monocyte through VCAM-1 and ICAM-1","volume":"905","author":"Shen","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2024.107308_bib373","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121917","article-title":"Liquid exfoliation of ultrasmall zirconium carbide nanodots as a noninflammatory photothermal agent in the treatment of glioma","volume":"292","author":"Liu","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.phrs.2024.107308_bib374","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1186\/s12951-021-01110-0","article-title":"Hybrid membrane-coated nanosuspensions for multi-modal anti-glioma therapy via drug and antigen delivery","volume":"19","author":"Hao","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.phrs.2024.107308_bib375","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202207768","article-title":"Cancer CEll-specific Fluorescent Prodrug Delivery Platforms","volume":"10","author":"Ma","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.phrs.2024.107308_bib376","doi-asserted-by":"crossref","first-page":"11676","DOI":"10.1021\/acsnano.1c08720","article-title":"Phage particles of controlled length and genome for in vivo targeted glioblastoma imaging and therapeutic delivery","volume":"16","author":"Tsedev","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.phrs.2024.107308_bib377","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202201968","article-title":"Graphene oxide nanoscale platform enhances the anti-cancer properties of bortezomib in glioblastoma models","volume":"12","author":"Sharp","year":"2023","journal-title":"Adv. Health Mater."},{"key":"10.1016\/j.phrs.2024.107308_bib378","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1134\/S0026893322060140","article-title":"Blood-brain barrier transwell modeling","volume":"56","author":"Petrovskaya","year":"2022","journal-title":"Mol. Biol."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661824002536?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661824002536?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T02:24:29Z","timestamp":1724466269000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661824002536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":378,"alternative-id":["S1043661824002536"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2024.107308","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Brain gliomas: Diagnostic and therapeutic issues and the prospects of drug-targeted nano-delivery technology","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2024.107308","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107308"}}